Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Clinical trial NCT00119249 · COMPLETED

Trial details

NCT number: NCT00119249
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Melanoma Stage IV Melanoma

Start date: 2005-06-01
Primary completion: 2007-11-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.